Medical/Pharmaceuticals
GC Biopharma/Novel Pharma's Sanfilippo Syndrome Treatment Obtains FDA IND Approval
YONGIN, South Korea, May 20, 2024 /PRNewswire/ -- GC Biopharma (006280. KS) and Novel Pharma announced that its jointly developed MPS IIIA 'GC1130A' treatment has received FDA IND approval. With this approval, development of 'GC1130A' is expected to accelerate with multinational clinical trial...
2024-05-20 14:07
1465
Subang Jaya Medical Centre Applauded by Frost & Sullivan as the Best Hospital Company of the Year in Malaysia for the fourth consecutive year
SJMC's significant efforts in alleviating nursing shortages, enhancing workflows and its strong market-leading position, both locally and globally resulted in high patient retention and strong referrals. SAN ANTONIO, May 20, 2024 /PRNewswire/ -- Frost & Sullivan recently analyzed the hospital in...
2024-05-20 10:00
1795
Hong Kong Breast Cancer Foundation Symposium on Breast Health Education 2024
Latest Breast Cancer Diagnosis and Treatment, Integrating Traditional Chinese Medicine and Mind-Body-Spirit Healing HONG KONG, May 20, 2024 /PRNewswire/ -- Breast cancer is the most common cancer among women inHong Kong, and the third leading cause of cancer-related deaths; affecting numerous fa...
2024-05-20 08:33
1523
Innovent Announces Oral Presentations at ESMO Plenary and ESMO GI Congress on Clinical Data of IBI363 (PD-1/IL-2) and IBI343 (CLDN18.2 ADC)
SAN FRANCISCO and SUZHOU, China, May 19, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune,...
2024-05-20 08:20
2285
Qilian International plans to adjust industrial investment
JIUQUAN, China, May 17, 2024 /PRNewswire/ -- Qilian International Holdings Group Limited (NASDAQ: QLI) ("Qilian" or the "Company"), a pharmaceutical and chemical products manufacturer headquartered inChina, today announced: In the past two years, Qilian International Holdings Group Limited has en...
2024-05-17 22:00
5599
HOYA Group Company, PENTAX of America, Inc. and MAGENTIQ EYE Ltd. Announce their Intention to Form a Distribution Partnership for the U.S Market
WASHINGTON D.C., May 17, 2024 /PRNewswire/ -- HOYA Group Company, PENTAX of America, Inc. (PENTAX Medical) and MAGENTIQ-EYE Ltd., an AI medical device company, announced today their intention to form a partnership in the field of AI in Gastroenterology and to examine further collaboration and str...
2024-05-17 22:00
5451
GV Announces Cooperation with Top 500 Company in China
TORONTO, May 17, 2024 /PRNewswire/ -- Visionary Holdings Inc. (the "Company") (NASDAQ: GV), a private education provider with technology of artificial intelligence and life science on the cutting edge, with subsidiaries inCanada and market partners inChina, today announced the Company and Red Sun...
2024-05-17 20:30
3248
LiveSpo Pharma Emerges as Vietnam's Pioneer at Vitafoods Europe 2024, Unveiling Groundbreaking Research and Product Development to Reduce Antibiotic Use in Digestive and Respiratory Care
HANOI, Vietnam, May 17, 2024 /PRNewswire/ -- LiveSpo Pharma is the first Vietnamese entity to report on clinical studies at Vitafoods Europe 2024, held inGeneva, Switzerland. LiveSpo Pharma showcased its range of high-concentration, multi-strain liquid medical probiotics products, affirming the ...
2024-05-17 18:33
4681
OMRON Healthcare's Presence at Heart Rhythm 2024 in the U.S.
KYOTO, Japan, May 17, 2024 /PRNewswire/ -- OMRON Healthcare Co., Ltd. based in Muko,Kyoto Prefecture, Japan, announced its presence at Heart Rhythm 2024, the Annual Meeting of the Heart Rhythm Society (HRS) in the U.S. At Heart Rhythm 2024, the Company will showcase its upper-arm blood pressure m...
2024-05-17 16:00
1724
Celltrion USA announces two-year data for ZYMFENTRA™(infliximab-dyyb) to be presented at Digestive Disease Week (DDW) 2024 Conference
* Data presentations including the extended LIBERTY studies to highlight the long-term treatment goals ofZYMFENTRA™, the first and only FDA-approved subcutaneous infliximab * The data underscores Celltrion's commitment to improving patient outcomes and advancing scientific understanding in th...
2024-05-17 12:01
1566
Full-Life Technologies Announces Appointment of Mark S. de Jong, PhD, as Chief Technical Officer
GEMBLOUX, Belgium, May 16, 2024 /PRNewswire/ -- Full-Life Technologies (Full-Life), a fully integrated global radiotherapeutics company, today announced the appointment ofMark S. de Jong, PhD, to the newly created position of Chief Technical Officer (CTO). Dr. de Jong, joins Full-Life with 43 yea...
2024-05-17 08:00
1351
Troy Animal Healthcare Strengthens Quality Operations with Veeva Vault Quality
Australian animal health leader adopts Veeva Vault QualityDocs and Veeva Vault
Training for greater efficiency and compliance
SYDNEY, May 17, 2024 /PRNewswire/ -- Troy Animal Healthcare and Veeva Systems
2024-05-17 07:00
16004
Seegene and Springer Nature Announce Strategic Alliance
- Strategic alliance aims to foster collaboration with researchers working in various disease fields by using best-in-class PCR diagnostic technology - Companies will facilitate C-level cooperation, strengthening the partnership for the SG OneSystem™ business (Seegene's technology-sharing busine...
2024-05-16 21:00
2968
Visionary Has World-Class Biochip Technology Products
TORONTO, May 16, 2024 /PRNewswire/ -- Visionary Holdings Inc. (the "Company") (NASDAQ: GV), a private education provider with technology of artificial intelligence and life science on the cutting edge, with subsidiaries inCanada and market partners inChina, today announced the Company has coopera...
2024-05-16 20:30
3095
M42 receives Global Healthcare Accreditation Certification for Excellence in Medical Travel Patient Experience
PALM BEACH GARDENS, Fla., May 16, 2024 /PRNewswire/ -- M42 has achieved the Global Healthcare Accreditation (GHA) certification for Excellence in Medical Travel Patient Experience from the US for its pioneering approach. With an overall score of 91 per cent, this certification reaffirms M42's com...
2024-05-16 18:00
1985
Fosun International Earns a Spot on "2024 Fortune China ESG Impact List"
HONG KONG, May 16, 2024 /PRNewswire/ -- On 13 May 2024, Fortune China magazine released the 2024 China ESG Impact List, and Fosun International Limited ("Fosun International" or the "Company") (HKEX stock code: 00656) was included in the list, highlighting its outstanding performance and industry...
2024-05-16 11:15
3857
HSA approves GSK's Arexvy, the world's first respiratory syncytial virus (RSV) vaccine for older adults [1]
* Arexvy has been approved by the Health Sciences Authority (HSA) of Singapore for active immunisation for the prevention of lower respiratory tract disease (LRTD) caused by respiratory syncytial virus (RSV) in individuals 60 years of age and older.[2] * Arexvy is 94.6% efficacious in prevent...
2024-05-16 10:00
2161
![HSA approves GSK's Arexvy, the world's first respiratory syncytial virus (RSV) vaccine for older adults [1]](https://mma.prnasia.com/media2/2412228/GSK_Asia_House_Singapore.jpg?p=medium600)
BAXTER ANNOUNCES MISSION AND LOGO FOR PROPOSED KIDNEY CARE COMPANY VANTIVE
DEERFIELD, Ill., May 16, 2024 /PRNewswire/ -- Baxter International Inc.
(NYSE:BAX), a global medtech leader, announced today the mission and logo for
its proposed kidney care and acute therapies company, to be namedVantive
2024-05-16 09:56
1750
EHA 2024 | Results from Five Studies of Ascentage Pharma's Key Drug Candidates Selected for Presentations at 2024 European Hematology Association Hybrid Congress
SUZHOU, China and ROCKVILLE, Md., May 15, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that the latest results from five studies have been ...
2024-05-16 09:03
1708
Nobel Laureate Jules Hoffmann's Team Collaborates with Infinitus on Advances in Polysaccharides and Immunity
GUANGZHOU, China, May 16, 2024 /PRNewswire/ -- Recently, Professor Jean-Luc, Director of the Institute of Molecular Cell Biology at the French National Centre for Scientific Research (CNRS), Member of the Infinitus Global Scientific Advisory Board, and Principal Investigator of Hoffmann Infinitus...
2024-05-16 02:02
2620
Week's Top Stories
Most Reposted
Rocket Travel by Agoda Shares Revealing New Report and Showcases Solution to Transform Hotel Distribution
[Picked up by 313 media titles]
2024-11-21 10:30Rockwell Automation and Microsoft Deliver on a Shared Vision to Accelerate Industrial Transformation
[Picked up by 308 media titles]
2024-11-20 13:29Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
[Picked up by 301 media titles]
2024-11-20 16:30
Travel loyalty programs to focus on offering personalized and flexible customer experiences in 2025
[Picked up by 298 media titles]
2024-11-19 10:42Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies
[Picked up by 284 media titles]
2024-11-20 09:00
Most Read
Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
2024-11-20 16:30
6801
